K-numberK251153
Device nameAurora
ApplicantGe Medical Systems Israel
Product codeKPS
Device classClass II
Decision dateJun 12, 2025
DecisionSubstantially Equivalent
Regulation892.1200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Aurora is a hybrid SPECT-CT imaging system for nuclear medicine procedures that detects radioactive tracer uptake and provides CT images for attenuation correction and anatomical localization. It is intended for general nuclear medicine imaging, head/body/cardiac/vascular CT applications, and aids in detecting, diagnosing, and assessing diseases including cardiovascular disease, neurological disorders, and cancer.

Technological characteristics

The proposed Aurora adds a deep-learning Automatic Kidney Segmentation algorithm to the predicate's Real-time Time Activity Curve software feature for Dynamic Renal Scintigraphy images. The algorithm automatically localizes and outlines kidneys to reduce manual steps, though the user must confirm the output. All other specifications—dual NaI-based detectors, Revolution Ascend CT subsystem, patient table, and scan ranges—remain identical to the predicate device (K243605).

Test standards cited

IEC 60601-1 and applicable Collateral and Particular Standards including IEC 60601-1-2, 60601-1-3, and 60601-2-44; NEMA NU-1 for performance testing; ISO 13485 quality system standards.

Substantial equivalence argument

The kidney segmentation algorithm does not change indications for use, intended use, energy type, operating principles, or control mechanisms from the predicate. Bench testing on 70 diverse clinical renal studies achieved DICE scores above predefined acceptance criteria, and clinical evaluation by three qualified U.S. readers confirmed acceptable segmentation quality with minimal user interaction. Design verification and risk management identified no new hazards, unexpected results, or adverse effects, demonstrating the device is as safe and effective as the legally marketed predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →